Loading...

Artemis Therapeutics Inc.

ATMS•PNK
Financial Services
Shell Companies
$0.50
$-1.39(-73.65%)

Artemis Therapeutics Inc. (ATMS) Stock Overview

Explore Artemis Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.3/100

Key Financials

Market Cap55.8M
P/E Ratio-21032.59
EPS (TTM)$-0.06
ROE1.78%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.65

ATMS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Artemis Therapeutics Inc. (ATMS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21032.59 and a market capitalization of 55.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-73.65%
3-Month Change
-2.16%
6-Month Change
-61.69%
Year-to-Date (YTD) Change
-57.07%
1-Year Change
-86.72%
3-Year Change
1145.00%
5-Year Change
-50.69%
All-Time (Max) Change
-97.85%

Contact Information

https://www.artemis-therapeutics.com
646 233 1454
18 East 16th Street, New York City, NY, 10003

Company Facts

4 Employees
IPO DateFeb 17, 1998
CountryUS

Frequently Asked Questions

;